Epidemiology and clinical record of multiple sclerosis in selected countries: a systematic review

Author： Niedziela Natalia   Adamczyk-Sowa Monika   Pierzchała Krystyna  

Publisher： Informa Healthcare

ISSN： 0020-7454

Source： International Journal of Neuroscience, Vol.124, Iss.5, 2014-05, pp. : 322-330

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

A review of the aetiology of multiple sclerosis: an ecological approach

By Murrell T.G.C.   Harbige L.S.   Robinson I.C.  

Annals of Human Biology, Vol. 18, Iss. 2, 1991-04 ,pp. : 95-112

Informa Healthcare

Access to resources Recommend Favorite

Tovaxin for multiple sclerosis

By Rivera Victor M  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 7, 2011-07 ,pp. : 961-967

Informa Healthcare

Access to resources Recommend Favorite

Alemtuzumab and multiple sclerosis: therapeutic application

By Alireza Minagar   J Steven Alexander   Mohammad Ali Sahraian   Robert Zivadinov  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 3, 2010-03 ,pp. : 421-429

Informa Healthcare

Access to resources Recommend Favorite

Current evaluation of alemtuzumab in multiple sclerosis

By Coyle Patricia Katherine  

Expert Opinion on Biological Therapy, Vol. 14, Iss. 1, 2014-01 ,pp. : 127-135

Informa Healthcare

Access to resources Recommend Favorite

On the Catalytic Activity of Autoantibodies in Multiple Sclerosis

By Ponomarenko N. A.   Durova O. M.   Vorob'ev I. I.   Suchkov S. V.   Gabibov A. G.  

Doklady Biochemistry & Biophysics, Vol. 395, Iss. 1-6, 2004-03 ,pp. : 120-123

MAIK Nauka/Interperiodica

Access to resources Recommend Favorite